Interview with Professor Geert Molenberghs

Geert Molenberghs

Geert Molenberghs

CHANCE invited Dr. Geert Molenberghs, professor of biostatistics at the Universiteit Hasselt and KU Leuven in Belgium, to talk with editor
Toshimitsu Hamasaki and executive editor Scott Evans.

Molenberghs is internationally recognized as a leading biostatistician. He has made important contributions to numerous areas of statistics, in particular methodological developments on surrogate markers in clinical trials, categorical data, longitudinal data analysis, and the analysis of non-response in clinical and epidemiological studies.

Molenberghs received his BS degree in mathematics and PhD in biostatistics from the Universiteit Antwerpen. He is founding director of the Center for Statistics at Hasselt University and currently director of the Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BioStat), a joint initiative of the Hasselt and Leuven universities.

Molenberghs has served as joint editor of Applied Statistics (2001–2004), co-editor of Biometrics (2007–2009), co-editor of Biostatistics (2010–2015), and president of the International Biometric Society (2004–2005).

Molenberghs was elected a Fellow of the American Statistical Association in 2003, and became an elected member of the International Statistical Institute in 2007. He has received numerous awards, including the Guy Medal in Bronze (2002) from the Royal Statistical Society; Outstanding Contribution to the Society Development by the International Biometric Society (2010); Best Contributed Paper Award from the Biopharmaceutical Section of the ASA (2005); Donald E. Francke Award for Overall Excellence in Journal Publishing from Drug Information Journal (2009); and Excellence in Continuing Education Award from the ASA in 2003, 2005, 2006, 2009, and 2011.

Some content is only viewable by Chance Subscribers
Tagged as: , , ,

Leave a Response

Please note: comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.